A Phase II Study of Topotecan in Patients with Relapsed Small-Cell Lung Cancer-Reference-Cited by-同舟云学术

A Phase II Study of Topotecan in Patients with Relapsed Small-Cell Lung Cancer

Published:2003-01 Issue:4 Volume:4 Page:224-228
ISSN:1525-7304
Container-title:Clinical Lung Cancer
language:en
Short-container-title:Clinical Lung Cancer

Author:

Takeda Koji,Negoro Shunichi,Sawa Toshiyuki,Nakagawa Kazuhiko,Kawahara Masaaki,Isobe Takeshi,Kudoh Shinzoh,Masuda Noriyuki,Niitani Hisanobu,Fukuoka Masahiro

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference23 articles.

1. Chemotherapy of Lung Cancer;Ihde;N Engl Med,1992

2. VP-16 and cisplatin as first-line therapy for small-cell lung cancer;Evans;J Clin Oncol,1985

3. Treatment options for patients with relapsed small cell lung cancer;Greco;Lung Cancer,1993

4. Synthesis of water-soluble (Aminoalkyl) camptothecin analogues: inhibition of topoisomerase I and antitumor activity;Kingsbury;J Med Chem,1991

5. Effect of p-glycoprotein expression on the accumulation and cytotoxicity of topotecan (SK&F 104864), a new camptothecin analogue;Hendricks;Cancer Res,1992

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Topotecan in a Real-World Small-Cell Lung Cancer Cohort: Prognostic Biomarkers Improve Selection of Patients for Second-Line Treatment;Diagnostics;2024-07-19

2. Efficacy of second-line chemotherapy in patients with pulmonary large cell neuroendocrine carcinoma;Scientific Reports;2024-04-01

3. Utilization of Antineoplastic Agents and Medicare Spending in Elderly Patients With Extensive-Stage Small-Cell Lung Cancer Between 2001 and 2013;JCO Oncology Practice;2020-07

4. Treatment strategy for patients with relapsed small-cell lung cancer: past, present and future;Translational Lung Cancer Research;2020-04

5. Topotecan monotherapy for the treatment of relapsed small cell lung cancer in elderly patients: A retrospective analysis;Thoracic Cancer;2018-10-03